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Abstract Hip protectors seemed to be the only non-
pharmacological intervention to effectively prevent hip
fractures in high-risk populations. In contrast, recently
published trials did not find hip fracture reduction through
hip protector interventions. An updated Cochrane review
concluded that the device is ineffective for community-
dwelling elderly and of uncertain effectiveness for institu-
tionalised elderly. However, some primary studies used
suboptimal implementation of hip protectors, which has led
to low adherence and ineffectiveness of the intervention.
Shortcomings in implementation techniques have not been
assessed by the Cochrane review. Therefore, reviewers
should explicitly assess whether the intervention was well
planned and competently administered. As a checklist
cannot adequately assess individual, study-specific imple-
mentation flaws, we suggest narrative expert review and
feedback to the authors of the primary study.
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Introduction
Hip fractures are a major cause of disability and functional
impairment among the elderly [12]. Most cases result from
fall-related direct impact on the greater trochanter of the
proximal femur [20, 27]. Fall prevention programmes have
been extensively studied. Multifaceted interventions may
prevent falls. There is no evidence that fall prevention
programmes reduce hip fractures [5]. National guidelines
recommend offering hip protectors to all nursing home
residents [4]. Hip protectors have been suggested to be the
only non-pharmacological intervention to effectively pre-
vent hip fractures in high-risk populations [10, 14, 16].
However, recently published trials did not demonstrate hip
fracture reduction through hip protector intervention [18,
24]. An updated Cochrane review concluded that hip
protectors are ineffective for community-dwelling elderly
and their effectiveness remains uncertain for institutional-
ised elderly [19]. However, the effectiveness of a hip
protector intervention depends on the baseline risk of the
population and the adherence to wear the device. Hip
protectors do not work unless they are worn at the time of
the fall. Suboptimal implementation of hip protectors might
lead to low adherence and, therefore, to ineffectiveness of
the intervention. We aim to illustrate that quality assessment
even within high-quality systematic reviews does not reflect
if the intervention programmes were well planned and
competently administered.
Materials and methods
We searched PubMed (to April 2006) to find systematic
reviews on hip protectors. Reference lists of the retrieved
two meta-analyses were reviewed to identify primary
studies. We present a brief overview of the external
evidence on hip protectors summarised in the Cochrane
review [19] and briefly discuss disagreement with the
review by Sawka et al. [23]. We analysed shortcomings in
implementation techniques, which cannot be identified by
the usual approach of critically appraising randomised
controlled trials. Therefore, we exemplarily focused on
two primary studies that the Cochrane reviewers rated as
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having very good methodological quality. Both studies [18,
24] received the largest weight in the meta-analysis of
institutional setting studies and had a major impact on the
interpretation of the effectiveness of hip protector inter-
ventions.
How hip protectors work
Hip protectors are devices designed to protect the hipbones
during a fall. Different protectors have been studied in
several randomised controlled trials in various countries
[19]. Most types consist of plastic shields or foam pads that
are held in place at the hips with specially designed
underwear. Energy shunting (hard-shelled) hip protectors
are made of durable plastic, designed to divert a direct
impact away from the greater trochanter onto the surround-
ing soft tissue. Soft hip pads primarily absorb energy.
Biomechanical studies suggest that the force-attenuating
capacity of the hard-shelled hip protectors is superior to
soft, energy-absorbing ones [11, 22, 25]. Only few hip
fractures have been reported with documented use of the
hip protector [16, 18, 24]. However, verification if the hip
protector was correctly used at the time of fall is difficult
[16].
The acceptance of hip protectors remains a problem.
Structured education and involvement of caregivers can
substantially improve adherence to hip protectors [16, 26].
External evidence on the effectiveness of hip protectors
The first randomised controlled trial investigating the
effectiveness of hip protectors in nursing home residents
was published 13 years ago [14], followed by several trials
and reviews on hip protector intervention programmes.
Recently, the sixth update of the Cochrane review was
published [19]. Figures 1 and 2 show the results of this
meta-analysis. The authors have pooled five trials that used
individual randomisation together with six cluster random-
ised trials. The studies were carried out in nursing homes
or residential homes. The results show a significant
reduction in hip fracture incidence [relative risk (RR)
0.77, 95% confidence interval (CI) 0.62 to 0.97]. However,
Fig. 1 Incidence of hip fractures in elderly participants provided with hip protectors or not in an institutional setting
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the upper limit of the confidence interval indicates marginal
statistical significance. Sensitivity analyses were carried out
because of statistical heterogeneity within the group of
cluster randomised trials. Removal of the trial by Kannus et
al. [10] results in loss of significant effectiveness of hip
protector interventions, whereas the significant effect
remains while removing the trial by O’Halloran [18]. Data
pooling of three individually randomised trials of hip
protector interventions in community-dwelling elderly
resulted in no reduction of hip fracture incidence (RR
1.16, 95% CI 0.85 to 1.59).
Discordance among systematic reviews on hip
protectors
Sawka et al. [23] suggested a more pronounced relative risk
reduction in nursing home residents allocated to hip
protector intervention (RR 0.50, 95% CI 0.28–0.91).
Assessment of study quality was a source of discordance
among the two meta-analyses. Inclusion criteria were
stricter in the review by Sawka et al. Five trials considered
in the Cochrane review were excluded due to violation of
randomisation [10, 14], lack of complete random allocation
[2, 8] and unit of analysis bias [3, 10, 14]. Although the trial
by O’Halloran et al. [18] has been published after finishing
literature search for the review by Sawka et al., the authors
stated that the trial would not have met their strict inclusion
criteria due to major methodological shortcomings.
Sawka et al. classified the population investigated by van
Schoor et al. [24] as community dwelling, whereas the
Cochrane review defined it as institutionalised. As half of the
study population consisted of elderly living in apartment
houses or homes for the elderly and half of nursing home
residents, both classifications have shortcomings. This prob-
lem is typical for meta-analyses that use aggregate, instead of
individual, patient data. The latter one is judged to be the
more valid method to summarise the results of multiple
studies [15]. It has been suggested that meta-analyses based
on aggregate patient data should be viewed as only
exploratory, as they do not provide reliable information [21].
Diversity of hip protector interventions
The Cochrane review [19] as well as the review by Sawka
et al. [23] quantitatively summarised studies regardless of
different co-interventions or different control group inter-
ventions. Most studies investigated the effects of a single
provision of protectors; other intervention programmes
comprised both education and information approaches and
provision of hip protectors [19]. The latter were more or
less complex interventions, which consist of components
that depend on each other and, therefore, cannot be
separated [1]. All trials except one used no intervention as
comparator. This one trial [16] offered optimised usual care
to the control group through information to nurses about
hip protectors and provision of protectors for demonstration
purposes. In both systematic reviews, trials were synthes-
ised through meta-analysis without exploring and consid-
ering clinical heterogeneity. Unlike statistical heterogeneity,
clinical heterogeneity due to different inclusion criteria,
manner of administration of interventions or measurement
of outcome parameters can be identified before data
analysis. Suggestions have been made on how to consider
clinical heterogeneity in systematic reviews [6].
Clinical flaws despite high-quality rating
of methodology
The Cochrane review [19] applied rigorous quality criteria
well-known to influence the validity of randomised
controlled trials [9]: allocation concealment, clear definition
Fig. 2 Incidence of hip fractures in elderly participants provided with hip protectors or not in the community
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of inclusion and exclusion criteria, loss to follow-up,
comparability of study groups, equal treatment of study
groups, except of the intervention, and intention-to-treat
analysis. Further criteria specially addressing hip protector
trial methodology were applied: active or scheduled follow-
up ascertainment and monitoring of adherence. However,
appraising trials using formal checklists may overlook
important clinical flaws in the original trials [7]. This can
be illustrated exemplarily by critical appraisal of two
included trials [18, 24]. The trials by van Schoor et al.
[24] and O’Halloran et al. [18] were chosen, as they
received the largest weight in the data pooling of
institutional setting studies (Fig. 1).
Van Schoor et al. [24] investigated the effectiveness of a
hip protector intervention programme in a heterogeneous
population of elderly living in apartment houses, residential
homes and nursing homes. The intervention did not result
in a reduction of hip fractures, and the authors claimed the
ineffectiveness of the hip protector.
However, the study has several important methodolog-
ical shortcomings. The power calculation was based on a
one-sided p value and a reduction of hip fractures of 75%.
Such a pronounced effect has never been shown before.
Sample-size calculation indicated the need of 700 partic-
ipants. However, only 561 participants were enrolled.
During the trial, follow-up was extended to 69.6 weeks to
increase the number of events.
The education approach used in the intervention group
was scarcely described. The underlying education theory
was not mentioned. Precise details of the interventions
intended for each group and how these were actually
administered were not given. The implementation of the
intervention may be less than optimal for the group of
cognitively impaired persons because there was no struc-
tured involvement of caregivers.
Van Schoor et al. emphasized single randomisation as an
important methodological strength of their study. However,
the avoidance of cluster randomisation seems to be
problematic in this setting. Contamination could have
compromised the study, as the same caregivers looked after
participants of both study groups.
Outcome assessment relied on participant-kept calendar.
As baseline data indicated cognitive impairment in approx-
imately 75% of participants, the reliability of the data is of
major concern. None of these obvious shortcomings has
been reflected in the Cochrane review, which classified the
trial of high methodological quality with a score of 10 out
of a possible 10.
The study by O’Halloran [18] is by far the largest trial
investigating a hip protector intervention in institutionalised
elderly. Thus, it received a weight of 46% in the meta-
analysis of the Cochrane review. The sample consisted of
127 nursing and residential homes with 4,117 beds in
Northern Ireland. The combined intervention of provision
of hip protectors, education and information did not result
in a reduction of hip fractures during 72 weeks of follow-
up. However, this study also has important methodological
shortcomings, which might have heavily affected the
results. A mixed population was investigated, including
nursing home residents and non-nursing home residents.
Baseline data of participants are not reported. It remains
unclear whether the two study groups were comparable at
the beginning of the study. A flow of participants through
the trial, which discloses the number of subjects with early
study termination and the proportion of subjects that have
been included after randomisation, is not given. The
absolute number of participating residents remains un-
known, as data are reported as events per 100 occupied
beds or per 100 residents per year.
The multifaceted intervention consisted of an educa-
tion session for home staff, distribution of manufacturer’s
information material, provision of a videotape on hip
protectors, information for residents and relatives on
request, counselling by a nurse facilitator and provision
of hip protectors for every resident agreeing to wear them.
No details are reported on how the education and
information programme was structured, whether it was
based on an education theory and if so, whether it had
been sufficiently explored before application. The reader
cannot assess if an appropriate intervention was admin-
istered. Access to the education programme is not
possible neither by further references nor authors’ offer
to contact them.
It remains unclear whether newly admitted residents also
received the information or whether residents and relatives
requested information sessions. It is of special concern that
the authors did not mention how and when the investigators
determined agreement to wear the hip protector. Frequency
of hip protector use in the control group was reported at
baseline only. However, during the time course of the trial a
successful hip protector trial has been published [10], and
hip protector use became a more common prevention
strategy. It is possible that an increasing number of control
group residents also used hip protectors.
Outcome measurement was based on routine documen-
tation of homes and chart review by the external nurse
facilitator. Numbers of falls, fallers and total fractures were
not reported and probably not ascertained. It remains
unclear if participants of the intervention and control
centres had a similar risk of suffering a hip fracture. The
reported significant difference in pelvic fractures suggests
that the use of the hip protector pads was not the only
important difference among the study groups.
Furthermore, the trial was limited, as seven out of 40
homes were not compliant with the introduction of the
intervention and outcome ascertainment compared to six
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out of 87 homes not cooperating in the control group.
Management of missing data has not been discussed.
Although the clustering design effect was considered in
the sample size calculation, the results were not adjusted for
the cluster effect.
In conclusion, critical appraisal of the study by O’Halloran
revealed several major methodological flaws. It seems that hip
protectors were disseminated to a heterogeneous group of
elderly using an unstructured, not theory-based education and
information approach. These biases affecting the internal
validity of the study have not been considered by the Cochrane
review. On the contrary, quality assessment by reviewers’
checklist indicated a score of 9 out of 10 [19].
Conclusion
It has been suggested previously that the assessment using a
methodological criteria checklist might end up with a high
score despite major mistakes [13]. Although formal
methodological criteria assessed within the Cochrane
review were fulfilled, the two studies used suboptimal
implementation practice and outcome collection. The
inferior quality of these trials means that their findings
must be questioned. The conclusion about ineffectiveness
of hip protectors drawn by the Cochrane review should,
therefore, be interpreted with caution.
What are the implications of our findings? They must
not be misinterpreted as a pleading not to use methodolog-
ical quality appraisal. Methodology of systematic reviews
has developed considerably during the past years. Guide-
lines have been developed to improve quality of meta-
analysis [17]. However, it is not enough to rely on the
author’s self-reported formal quality criteria. Reviewers
should go one step further and explicitly assess the quality
of the intervention not only the methodological quality. A
standardised set of criteria on the quality of implementation
can only inadequately assess individual, study-specific
methodological flaws. We suggest a narrative expert review
on quality of implementation techniques and feedback to
the authors of the primary study to clarify ambiguous issues
and to confirm reviewers’ judgment. Our recommendation
has been forwarded to the Cochrane Collaboration.
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